Get started
Author

Jason M Doherty

Observed names: Jason Doherty, Jason M. Doherty
ORCID: 0000-0002-9399-8214
Observed ORCID: 0000-0002-9399-8214
OpenAlex ID: A5022717459
Outcomes with androgen-deprivation therapy (ADT) plus androgen receptor pathway inhibitors (ARPIs) in veterans with de novo metastatic castration-sensitive prostate cancer (mCSPC) who were elderly, frail, or had high comorbidity: A subgroup analysis of enzalutamide and high-volume disease.
2026 · Martin W. Schoen, Jason M. Doherty, et al. · Journal of Clinical Oncology · 1
Treatment Intensity and Delays Associated With Antibiotic Prescribing Prior to Head and Neck Cancer Diagnosis
2026 · Austin T. Armstrong, Jonathan Brewer, et al. · Clinical Otolaryngology
PDF
Enteral Nutrition Support and Short-Term Weight Outcomes in Pediatric Avoidant/Restrictive Food Intake Disorder and Anorexia Nervosa During Inpatient Medical Stabilization: A Retrospective Cohort Study
2026 · Elizabeth M. Noonan, Jason M. Doherty, et al. · Nutrients
Effect of Testosterone on Asthma Exacerbations
2026 · Yash Nayak, Ekamjit Deol, et al. · Endocrine Practice
Overall survival in veterans with metastatic hormone sensitive prostate cancer by initial therapy and STRATOS-P somatic tumor classification.
2026 · Robert Wilson, Abigail Chu, et al. · Journal of Clinical Oncology
PDF
STRATOS-P clinical model for prognosis and selection of patients with metastatic hormone sensitive prostate cancer (mHSPC) for intermittent therapy.
2026 · Martin W. Schoen, Joshua Gruber, et al. · Journal of Clinical Oncology
Real World Hospitalizations in US Veterans Treated for Metastatic Prostate Cancer with Combination Therapy
2025 · Kara Ingram, Robert Wilson, et al. · Clinical Genitourinary Cancer
Relationships Between Markers of Iron Status and Hematological Parameters in Patients With Sickle Cell Disease
2024 · Nermi L. Parrow, Jason M. Doherty, et al. · Advances in Hematology
PDF
Works count: 8
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type